Annual Report

Overview

The report describes Sequana Medical's 2021 progress as a commercial-stage medical-device company. It completed POSEIDON enrolment with 71 pivotal-cohort patients, reported strong RED DESERT results including more than 150% improvement in diuretic response, and advanced the SAHARA DESERT study. The report also records 2021 revenue of EUR 370,500 and a net loss of EUR 23,615,081.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2021
Period: Ends 31 December 2021
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services